$1.86B
$15,000
0.0% of portfolio
483
Q4 2024
Added 118.55%
$6.03B
$1.1 Million
0.0% of portfolio
15,675
Q4 2024
Reduced 8.49%
$1.45B
$4,000
0.0% of portfolio
2,352
Q4 2024
Reduced 25.69%
-
$0
0.0% of portfolio
-
Q4 2022
New
$1.66B
$13,000
0.0% of portfolio
619
Q4 2024
Reduced 5.5%
$55.2M
$458,000
0.0% of portfolio
64,266
Q4 2024
Reduced 3.56%
$224M
$9,000
0.0% of portfolio
1,894
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 7.14%
$357M
$32,000
0.0% of portfolio
17,624
Q3 2024
New
$2.09B
$47,000
0.0% of portfolio
1,719
Q4 2024
Added 0.47%
$2.13B
$3.12 Million
0.0% of portfolio
16,761
Q4 2024
Added 0.85%
$9.56B
$119,000
0.0% of portfolio
6,494
Q1 2024
Added 30.72%
$2.97B
$389,000
0.0% of portfolio
6,399
Q4 2024
Reduced 23.21%
$8.41B
$1.41 Million
0.0% of portfolio
21,772
Q4 2024
Added 2.89%
$2.29B
$315,000
0.0% of portfolio
3,945
Q4 2024
Reduced 32.61%
-
$0
0.0% of portfolio
-
Q4 2024
New
$11.1B
$311,000
0.0% of portfolio
15,846
Q4 2024
Reduced 6.12%
$5.83B
$394,000
0.0% of portfolio
10,438
Q4 2024
Reduced 0.42%
$128M
$25,000
0.0% of portfolio
13,654
Q4 2024
Reduced 0.78%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 5.41%
$1.28B
$21,000
0.0% of portfolio
1,195
Q4 2024
Added 52.62%
$1.09B
$32,000
0.0% of portfolio
160
Q4 2024
Reduced 5.33%
$16.7B
$1.89 Million
0.0% of portfolio
19,390
Q4 2024
Reduced 5.28%
$3.27B
$11,000
0.0% of portfolio
2,631
Q4 2024
Reduced 64.9%
$2.96B
$1.11 Million
0.0% of portfolio
98,932
Q4 2024
Added 6,544.19%
$3.05B
$165,000
0.0% of portfolio
23,980
Q4 2024
Added 17.53%
$2.64B
$417,000
0.0% of portfolio
11,388
Q4 2024
Added 38.84%
-
$0
0.0% of portfolio
-
Q3 2024
New
$7.51B
$368,000
0.0% of portfolio
6,691
Q4 2024
Reduced 50.99%
$1.2B
$472,000
0.0% of portfolio
5,025
Q4 2024
Added 575.4%
$5.12B
$53,000
0.0% of portfolio
2,460
Q4 2024
Reduced 50.49%
$3.74B
$1.76 Million
0.0% of portfolio
27,090
Q4 2024
Added 82.53%
$2.46B
$923,000
0.0% of portfolio
15,087
Q4 2024
Added 15.08%
$0
$138,000
0.0% of portfolio
12,787
Q1 2024
Reduced 26.91%
$0
$134,000
0.0% of portfolio
12,527
Q4 2024
Added 12.58%
$3.72B
$376,000
0.0% of portfolio
10,155
Q4 2024
Reduced 10.05%
$446M
$17,000
0.0% of portfolio
633
Q4 2024
Added 195.79%
$9.39B
$822,000
0.0% of portfolio
7,608
Q4 2024
Reduced 11.75%
$278M
$1,000
0.0% of portfolio
739
Q4 2024
Reduced 58.53%
$10.7B
$503,000
0.0% of portfolio
13,976
Q4 2024
Reduced 3.72%
$30.7B
$1.13 Million
0.0% of portfolio
4,782
Q4 2024
Reduced 14.27%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$0
$78,000
0.0% of portfolio
2,413
Q4 2024
Added 27.47%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 3.3%
$2.3B
$21,000
0.0% of portfolio
109
Q4 2024
Added 45.33%
$1.2B
$9,000
0.0% of portfolio
983
Q4 2024
Reduced 5.48%
$5.81B
$139,000
0.0% of portfolio
1,277
Q4 2024
Reduced 80.57%
$280M
$10,000
0.0% of portfolio
1,405
Q4 2024
Added 87.33%
$0
$0
0.0% of portfolio
681
Q3 2024
Added 581.0%
$2.2B
$20,000
0.0% of portfolio
366
Q3 2024
Reduced 33.21%